Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 521584, 6 pages
http://dx.doi.org/10.1155/2015/521584
Review Article

Resistance to Antibiotics and Antifungal Medicinal Products: Can Complementary and Alternative Medicine Help Solve the Problem in Common Infection Diseases? The Introduction of a Dutch Research Consortium

1University of Applied Sciences, 2333 CK Leiden, Netherlands
2Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK
3Department of Healthcare and Nutrition, Louis Bolk Institute, 2972 LA Driebergen, Netherlands
4Department of Health Sciences, Mid Sweden University, 871 31 Sundsvall, Sweden
5National Information and Knowledge Centre on Integrative Medicine (NIKIM), Amsterdam, Netherlands
6Naturalis Biodiversity Center, 2333 CR Leiden, Netherlands

Received 29 June 2015; Accepted 25 August 2015

Academic Editor: Cheryl Hawk

Copyright © 2015 Esther T. Kok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. McDermott and D. E. Rogers, “Social ramifications of control of microbial disease,” Johns Hopkins Medical Journal, vol. 151, no. 6, pp. 302–312, 1982. View at Google Scholar · View at Scopus
  2. J. O'Neil, Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, WEST, 2014.
  3. R. E. McFayden, “The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co,” Bulletin of the History of Medicine, vol. 53, no. 2, pp. 159–169, 1979. View at Google Scholar
  4. P. Heusser, Ed., Akademische Forschung in der Anthroposophischen Medizin. Beispiel Hygiogenese: Natur- und geisteswissenschaftliche Zugänge zur Selbstheilungskraft des Menschen, Peter Lang, Bern, Switzerland, 1999.
  5. P. Heusser, “Physiologische grundlagen der gesundheitsförderung und das anthroposophisch-medizinische Konzept,” in Gesundheitsförderung- eine neue Zeitforderung Interdisziplinäre Forschung und Beitrag der Komplementärmedizin, P. Heusser, Ed., vol. 6, pp. 101–129, Peter Lang, Bern, Switzerland, 2002. View at Google Scholar
  6. D. Raoult, P. E. Fournier, and M. Drancourt, “What does the future hold for clinical microbiology?” Nature Reviews Microbiology, vol. 2, no. 2, pp. 151–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. F. A. Waldvogel, “Infectious diseases in the 21st century: old challenges and new opportunities,” International Journal of Infectious Diseases, vol. 8, no. 1, pp. 5–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. F. R. Mooi, I. H. M. van Loo, and A. J. King, “Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?” Emerging Infectious Diseases, vol. 7, no. 3, pp. 526–528, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Mölstad, C. S. Lundborg, A.-K. Karlsson, and O. Cars, “Antibiotic prescription rates vary markedly between 13 European countries,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 5, pp. 366–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Patrick, F. Marra, J. Hutchinson, D. L. Monnet, H. Ng, and W. R. Bowie, “Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?” Clinical Infectious Diseases, vol. 39, no. 1, pp. 11–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. http://www.cdc.gov/.
  12. S. Harbarth, W. Albrich, and C. Brun-Buisson, “Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective,” Emerging Infectious Diseases, vol. 8, no. 12, pp. 1460–1467, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Norrby, C. E. Nord, and R. Finch, “Lack of development of new antimicrobial drugs: a potential serious threat to public health,” Lancet Infectious Diseases, vol. 5, no. 2, pp. 115–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Larson, “Community factors in the development of antibiotic resistance,” Annual Review of Public Health, vol. 28, pp. 435–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. N. Werk and H. Bauchner, “Practical considerations when treating children with antimicrobials in the outpatient setting,” Drugs, vol. 55, no. 6, pp. 779–790, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Leach, “Public, nurse and medical practitioner attitude and practice of natural medicine,” Complementary Therapies in Nursing and Midwifery, vol. 10, no. 1, pp. 13–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. http://www.efcam.eu.
  18. http://www.cbs.nl.
  19. A. Busato, A. Dönges, S. Herren, M. Widmer, and F. Marian, “Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland-an observational study,” Family Practice, vol. 23, no. 6, pp. 116–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. F. M. Sirois and R. J. Purc-Stephenson, “Consumer decision factors for initial and long-term use of complementary and alternative medicine,” Complementary Health Practice Review, vol. 13, no. 1, pp. 3–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Vlieger, M. van Vliet, and M. C. Jong, “Attitudes toward complementary and alternative medicine: a national survey among paediatricians in the Netherlands,” European Journal of Pediatrics, vol. 170, no. 5, pp. 619–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Herman, B. M. Craig, and O. Caspi, “Is complementary and alternative medicine (CAM) cost-effective? A systematic review.,” BMC Complementary and Alternative Medicine, vol. 5, article 11, 2005. View at Google Scholar · View at Scopus
  23. P. Kooreman and E. W. Baars, “Patients whose GP knows complementary medicine tend to have lower costs and live longer,” European Journal of Health Economics, vol. 13, no. 6, pp. 769–776, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Kooreman and E. W. Baars, “A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs,” BMJ Open, vol. 4, no. 8, Article ID e005332, 2014. View at Publisher · View at Google Scholar
  25. S. Singh and E. Ernst, Trick or Treatment: The Undeniable Facts about Alternative Medicine, W.W. Norton & Company, New York, NY, USA, 2008.
  26. M. Teut and K. Linde, “Scientific case research in complementary and alternative medicine-a review,” Complementary Therapies in Medicine, vol. 21, no. 4, pp. 388–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. CAMbrella, The Roadmap to European CAM Research An Explanation of the CAMbrella Project and Its Key Findings, CAMbrella, 2012.
  28. H. J. Hamre, M. Fischer, M. Heger et al., “Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study,” Wiener Klinische Wochenschrift, vol. 117, no. 7-8, pp. 256–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Goksör, B. Alm, R. Pettersson et al., “Early fish introduction and neonatal antibiotics affect the risk of asthma into school age,” Pediatric Allergy and Immunology, vol. 24, no. 4, pp. 339–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Muc, C. Padez, and A. M. Pinto, “Exposure to paracetamol and antibiotics in early life and elevated risk of asthma in childhood,” Advances in Experimental Medicine and Biology, vol. 788, pp. 393–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Tsakok, T. M. McKeever, L. Yeo, and C. Flohr, “Does early life exposure to antibiotics increase the risk of eczema? A systematic review,” British Journal of Dermatology, vol. 169, no. 5, pp. 983–991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G. S. Kienle, H.-U. Albonico, L. Fischer et al., “Complementary therapy systems and their integrative evaluation,” Explore, vol. 7, no. 3, pp. 175–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Melchart, E. Walther, K. Linde, R. Brandmaier, and C. Lersch, “Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial,” Archives of Family Medicine, vol. 7, no. 6, pp. 541–545, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Barrett, M. Vohmann, and C. Calabrese, “Echinacea for upper respiratory infection,” Journal of Family Practice, vol. 48, no. 8, pp. 628–635, 1999. View at Google Scholar · View at Scopus
  35. B. Madikizela, A. R. Ndhlala, J. F. Finnie, and J. V. Staden, “In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 840719, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. G. Jepson and J. C. Craig, “Cranberries for preventing urinary tract infections,” Cochrane Database of Systematic Reviews, Article ID CD001321, 2008. View at Google Scholar · View at Scopus
  37. M. A. J. Beerepoot, G. Ter Riet, S. Nys et al., “Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women,” Archives of Internal Medicine, vol. 171, no. 14, pp. 1270–1278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Gv, “A general overwie on past, present and future antimycotics,” The Open Mycology Journal, vol. 4, pp. 22–32, 2010. View at Google Scholar
  39. J. F. Höfling, R. C. Mardegan, P. C. Anibal, V. F. Furletti, and M. A. Foglio, “Evaluation of antifungal activity of medicinal plant extracts against oral Candida albicans and proteinases,” Mycopathologia, vol. 172, no. 2, pp. 117–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Pirmohamed, “Drug-grapefruit juice interactions: two mechanisms are clear but individual responses vary,” British Medical Journal, vol. 346, article f1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Aboellil and M. Al-Tuwaijri, “Effect of some alternative medicine and biological factors on Candida albicans in Saudi Arabia,” Journal of Yeast and Funfal Research, vol. 1, pp. 100–107, 2010. View at Google Scholar
  42. https://nccih.nih.gov/.